HS

Hestia Insight IncOOTC HSTA Stock Report

Last reporting period 31 May, 2024

Updated 16 Oct, 2024

Last price

Market cap $B

0.003

Micro

Exchange

OOTC - OTC

HSTA Stock Analysis

HS

Uncovered

Hestia Insight Inc is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

138/100

High score

Market cap $B

0.003

Dividend yield

Shares outstanding

27.939 B

Hestia Insight, Inc. operates as an advisory company, which, through its subsidiaries, provides strategic consulting, medical supply sales support, management, and capital market advisory services for selective companies in the healthcare and biotech sectors. The company is headquartered in Las Vegas, Nevada and currently employs 3 full-time employees. The company went IPO on 2008-02-08. The firm is focused primarily on the healthcare and biotech sectors, through its two wholly owned operating subsidiaries, Hestia Investments Inc. (Hestia Investments), and HSTA HEALTH INC., doing business as Hestia Vending. Hestia Investments provides strategic consulting, medical supply sales and marketing support, management, and capital markets advisory services for select micro, small and medium-sized companies within the healthcare and biotech sectors. Hestia Vending operates within the healthy food, beverage and wellness products industry and the smart vending machine industry. The company is focused on making acquisitions of emerging growth companies with sciences and technologies. The company also intends to pursue the acquisition and development of healthcare-related technologies in the healthcare and biotech sectors through acquisition, licensing, or joint ventures.

View Section: Eyestock Rating